Piazza E, Donelli MG, Broggini M, Sessa C, Natale N, Ottolenghi L, Marsoni S, Libretti A, Mangioni C, Morasca L

Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.

Cancer Treat Rep 1980; 845-54.

Leggi ora
Ottolenghi L, Morasca L, Marsoni S, Piazza E, Soresi E, Libretti A, Garattini S

Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.

Biomedicine 1980; 123-7.

Leggi ora
Scita G, Darwiche N, Greenwald E, Rosenberg M, Politi K, De Luca LM

Retinoic acid down-regulation of fibronectin and retinoic acid receptor alpha proteins in NIH-3T3 cells. Blocks of this response by ras transformation.

J Biol Chem 1996; 6502-8. doi: 10.1074/jbc.271.11.6502

Leggi ora
Hashimoto Y, Costanzo V

Studying DNA replication fork stability in Xenopus egg extract.

Methods Mol Biol 2011; 437-45. doi: 10.1007/978-1-61779-129-1_25

Leggi ora
Marsoni S, Wittes R

Clinical development of anticancer agents--a National Cancer Institute perspective.

Cancer Treat Rep 1984; 77-85.

Leggi ora
O'Dwyer PJ, Shoemaker DD, Jayaram HN, Johns DG, Cooney DA, Marsoni S, Malspeis L, Plowman J, Davignon JP, Davis RD

Tiazofurin: a new antitumor agent.

Invest New Drugs 1984; 79-84. doi: 10.1007/BF00173791

Leggi ora
Shoemaker DD, O'Dwyer PJ, Marsoni S, Plowman J, Davignon JP, Davis RD

Spiromustine: a new agent entering clinical trials.

Invest New Drugs 1983; 303-8. doi: 10.1007/BF00177413

Leggi ora
Scita G, Wolf G

The effect of sphingosine on the release of fibronectin from human lung fibroblasts.

Biochim Biophys Acta 1994; 29-35. doi: 10.1016/0167-4889(94)90070-1

Leggi ora
O'Dwyer PJ, Alonso MT, Leyland-Jones B, Marsoni S

Teniposide: a review of 12 years of experience.

Cancer Treat Rep 1984; 1455-66.

Leggi ora
Hashimoto Y, Ray Chaudhuri A, Lopes M, Costanzo V

Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis.

Nat Struct Mol Biol 2010; 1305-11. doi: 10.1038/nsmb.1927

Leggi ora
Scita G, Wolf G

Retinoic acid and beta-carotene inhibit fibronectin synthesis and release by fibroblasts; antagonism to phorbol ester.

Carcinogenesis 1994; 1043-8. doi: 10.1093/carcin/15.5.1043

Leggi ora
Libretti A, Piazza E, Scanni A, Tomirotti M, Biraghi M, Scapaticci R, Bianchi C, Restelli G, Scarpazza G, Calzavara MP, Marsoni S, Morasca L

Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: a phase II study.

Cancer Treat Rep 1981; 171-2.

Leggi ora
Macdonald JS, Marsoni S, Bruno S, Poster D

Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.

Recent Results Cancer Res 1982; 323-30. doi: 10.1007/978-3-642-81685-7_52

Leggi ora
Ottonello S, Scita G, Mantovani G, Cavazzini D, Rossi GL

Retinol bound to cellular retinol-binding protein is a substrate for cytosolic retinoic acid synthesis.

J Biol Chem 1993; 27133-42.

Leggi ora
Cosentino C, Grieco D, Costanzo V

ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair.

EMBO J 2011; 546-55. doi: 10.1038/emboj.2010.330

Leggi ora
Pisoni MB, Libretti A, Piazza E, Vago G, Scapaticci R, Bianchi C, Tomirotti M, Scanni A, Calzavara MP, Cassani L, Scarpazza G, Marsoni S, Morasca L

Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.

Cancer Treat Rep 1981; 731-2.

Leggi ora
Ottolenghi I, Piazza E, Marsoni S, Trabattoni A, Natale N, Recchia M, Morasca L

Vincristine and bleomycin do not interfere with infusional plasma levels of methotrexate.

Eur J Cancer (1965) 1981; 365-6. doi: 10.1016/0014-2964(81)90129-8

Leggi ora
Poster DS, Penta J, Marsoni S, Bruno S, Macdonald JS

Bis-diketopiperazine derivatives in clinical oncology: ICRF-159.

Cancer Clin Trials 1980; 315-20.

Leggi ora
Morasca L, Marsoni S, Pisoni MB, Piazza E, Vago G, Casali W, Cogo R, Bianchi C, Scapaticci R

VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinoma.

Cancer Chemother Pharmacol 1982; 209-10. doi: 10.1007/BF00254551

Leggi ora
Marsoni S

Dilemmas in the development of cytoxic drug analogues.

Eur J Cancer 1992; 1594-5. doi: 10.1016/0959-8049(92)90047-6

Leggi ora
Marsoni S, Valsecchi MG

Prognostic factors analysis in clinical oncology: handle with care.

Ann Oncol 1991; 245-7. doi: 10.1093/oxfordjournals.annonc.a057928

Leggi ora
Scheidl H, Scita G, Sampson PH, Park HY, Wolf G

The effect of sphingosine and phorbol ester on the signal transduction enzymes and fibronectin release in cell culture.

Biochim Biophys Acta 1992; 295-300. doi: 10.1016/0167-4889(92)90234-3

Leggi ora
Kagan VE, Serbinova EA, Forte T, Scita G, Packer L

Recycling of vitamin E in human low density lipoproteins.

J Lipid Res 1992; 385-97.

Leggi ora
Tsuchiya M, Scita G, Freisleben HJ, Kagan VE, Packer L

Antioxidant radical-scavenging activity of carotenoids and retinoids compared to alpha-tocopherol.

Methods Enzymol 1992; 460-72. doi: 10.1016/0076-6879(92)13148-q

Leggi ora
Arrigo C, Koier IJ, McVie JG, Marsoni S, Newlands E, Schwartsmann G

Minimal guidelines for the monitoring of early clinical trials (phase I-II) in Europe under CRC/EORTC/NCI joint agreement.

Eur J Cancer 1992; 1289-92.

Leggi ora
%PLACEHOLDER%